Gsa Capital Partners LLP Abbott Laboratories Transaction History

Gsa Capital Partners LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 16, 2024	BUY	$90.19 - $110.4 $241,528 - $295,651	2,678 New	2,678 $294,000
Q1 2023 May 12, 2023	BUY	$96.86 - $114.01 $331,358 - $390,028	3,421 New	3,421 $346,000
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $961,416 - $1.17 Million	-8,432 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $221,008 - $270,612	-1,913 Reduced 18.49%	8,432 $1.19 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $1.21 Million - $1.34 Million	10,345 New	10,345 $1.22 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $1.22 Million - $1.79 Million	-19,476 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$78.51 - $87.4 $1.53 Million - $1.7 Million	19,476 New	19,476 $1.69 Million
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $207,270 - $241,740	-2,844 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $798,348 - $965,203	-12,056 Reduced 80.91%	2,844 $227,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $976,844 - $1.11 Million	14,900 New	14,900 $1.08 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $365,042 - $440,380	-6,003 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$57.57 - $63.54 $718,185 - $792,661	-12,475 Reduced 67.51%	6,003 $366,000
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $1.04 Million - $1.18 Million	18,478 New	18,478 $1.11 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $371,304 - $397,519	-6,917 Closed	0 $0
Q3 2017 Nov 20, 2017	BUY	$48.06 - $53.64 $332,431 - $371,027	6,917	6,917 $369,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.